Table: Sapporo Clinical Lab -Q1 group results

Sapporo Clinical Laboratory

07/08/2023 07:30

Aug 7 (Reuters)- 
             Sapporo Clinical Laboratory Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2023        Jun 30, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             4.92                4.90             19.56    
                 (+0.5 pct)          (+5.6 pct)       (-2.8 pct)  
  Operating        75 mln              131 mln          541 mln   
                 (-42.5 pct)         (-55.0 pct)      (-46.3 pct) 
  Recurring        80 mln              223 mln          486 mln   
                 (-63.8 pct)         (-23.9 pct)      (-58.0 pct) 
  Net               5 mln              78 mln           307 mln   
                 (-92.7 pct)         (-27.1 pct)      (-45.9 pct) 
  EPS             1.72 yen            23.35 yen        92.28 yen  
  Ann Div                             23.00 yen        23.00 yen  
  -Q2 div                                NIL              NIL     
  -Q4 div                             23.00 yen        23.00 yen  
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T